Estimating cure proportion in cancer clinical trials using flexible parametric cure models
Abstract Background In the context of survival analysis in recent cancer clinical trials, there has been an increasing interest in the proportion of patients who are not susceptible to the event, known as the cure proportion. To estimate it, cure models implicitly specify the time point when patient...
| الحاوية / القاعدة: | BJC Reports |
|---|---|
| المؤلفون الرئيسيون: | , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
Nature Portfolio
2024-08-01
|
| الوصول للمادة أونلاين: | https://doi.org/10.1038/s44276-024-00092-4 |